Stocks moving higher on the rumored Alexion/ Roche deal include BioMarin (BMRN +7.7%) — which is already the subject of takeout rumors — Vertex Pharmaceuticals (VRTX +3.5%), Regeneron (REGN +6.9%), and the iShares Biotech ETF (IBB +2.4%).